Bumetanide recalls
Bumetanide products have been recalled 3 times, most recently on 31 Oct 2018. The recalling company is usually Upsher Smith Laboratories. The most common reason is potency & assay.
Total recalls3since 2013
Last 12 months0reported
Class I00% of total
Ongoing0latest 31 Oct 2018
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 67%Class III 1 33%
Why bumetanide is recalled
Companies
By year
All bumetanide recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Bumetanide Tablets, USP, 1 mg recalled by Upsher Smith LaboratoriesBumetanide | Upsher Smith Laboratories | Potency & Assay | Nationwide |
| Drug | CLASS II | Bumetanide Tablets, USP, 2 mg recalled by Upsher Smith LaboratoriesBumetanide | Upsher Smith Laboratories | Potency & Assay | Nationwide |
| Drug | CLASS III | Bumetanide Tablets USP 5 mg recalled by SandozBumetanide | Sandoz | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.